Results 201 to 210 of about 117,022 (301)

New evidence supports a greater focus on streptococcal skin infections to prevent rheumatic fever. [PDF]

Med J Aust
Baker MG, Bennett J, Percival T, Leversha A, Gurney J, Moreland NJ.   +5 more
europepmc   +1 more source

Pastinaca sativa L.: Nutritional Composition, Phytochemistry, and Pharmacological Properties Supporting Its Potential as a Functional Food and Therapeutic Agent

Food Science &Nutrition, Volume 14, Issue 5, May 2026.
Food‐grade processing of Pastinaca sativa (parsnip) converts a nutrient‐rich plant matrix (dietary fiber, fructans, phenolics) through washing/slicing/enzymatic treatment and ingredient preparation into functional food ingredients, including fiber concentrates, antioxidant‐rich fractions, and parsnip powders/extracts.
Somanjana Khatua, Anish Nag, Surajit Sen, Jit Sarkar, Krishnendu Acharya, Daniela Calina, William N. Setzer, Javad Sharifi‐Rad   +7 more
wiley   +1 more source

Longitudinal surveillance of group A streptococcal pharyngitis and impetigo in remote Western Australian school children informs acute rheumatic fever prevention. [PDF]

PLOS Glob Public Health
Pickering J, Barth DD, Wong B, McKinnon E, Mullane M, Whelan A, Mikucki A, Dalton R, Ford A, Cinanni G, Joseph J, Hayes AJ, Davies MR, Whitcombe A, Moreland NJ, Bedford L, Winslow S, Jacky J, Macarthur R, Kneebone S, Ozies N, Lawford D, Carapetis J, Bowen AC, Missing Piece Study Surveillance Team.   +24 more
europepmc   +1 more source

The Current Use and Future Perspectives of Biosimilars in Pediatric Healthcare: A Narrative Review

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims The integration of biosimilars into pediatric healthcare represents a significant evolution in treatment accessibility and cost‐effectiveness. Biosimilars—biological products highly similar to already approved biologics, have emerged as promising alternatives for managing chronic and rare pediatric conditions, including ...
Zubaier Ahmed, Tasfiah Tasnim Maha, Sanjana Nowsher, Wasima Taslim, Fatema‐Tuz‐Zohora, Sabrina Sharmin, Hasina Yasmin   +6 more
wiley   +1 more source

Acute Rheumatic Fever and Rheumatic Heart Disease in Children Aged Less Than 5 Years in the Northern Territory Between 2010 and 2020. [PDF]

J Paediatr Child Health
Stephenson Z, Jones B, Remenyi B, de Dassel J, Dunn S, Francis JR, Yan J.   +6 more
europepmc   +1 more source

Herpes Zoster Vaccine Awareness and Uptake Among Older Adults in Saudi Arabia: Insights for Public Health, Preventive Medicine, and Primary Care Practice

Journal of General and Family Medicine, Volume 27, Issue 3, May 2026.
ABSTRACT Background/Objectives Complications from Herpes Zoster (HZ) are common among older adults and immunosuppressed populations. The HZ vaccine is a clinically and financially superior alternative to antiviral medications. However, a knowledge gap exists within the population regarding HZ and the vaccine.
Adam F. Aldhawyan, Mohammed A. BuSaad, Hasan M. Alswiket, Abdullah M. Alradhi, Ryad F. Alamry, Fadel A. Almulla, Amjad Z. Boarish, Reema J. Alghamdi, Abdullatif K. Althunyan, Amani M. AlQarni   +9 more
wiley   +1 more source

A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease. [PDF]

Front Cell Infect Microbiol
Zhuang S, Guo D, Yu D.
europepmc   +1 more source

Acquired Angioedema Associated With Systemic Lupus Erythematosus Presenting as Acute Abdomen: A Case Report

Journal of General and Family Medicine, Volume 27, Issue 3, May 2026.
ABSTRACT Acquired angioedema (AAE) due to C1 inhibitor deficiency can present as acute abdomen. A 24‐year‐old woman developed severe abdominal pain and bowel wall edema initially suggestive of hereditary angioedema, but genetic testing excluded it. She later manifested fever, arthritis, rash, and serological abnormalities consistent with systemic lupus
Seiji Shiota, Shogo Kodama, Kouichirou Tahara   +2 more
wiley   +1 more source

Epidemiological and Clinical Manifestations of Acute Rheumatic Fever in Far North Queensland, Australia. [PDF]

Pathogens
Crous M, Hempenstall A, Lui-Gamia N, Taunton C, Hanson J.   +4 more
europepmc   +1 more source

Long‐Term Safety and Efficacy of Pegvaliase in Japanese Adults With Phenylketonuria: Final Results of a Phase III Trial

JIMD Reports, Volume 67, Issue 3, May 2026.
ABSTRACT Phenylketonuria (PKU) is an inborn error of metabolism leading to phenylalanine (Phe) accumulation and consequent neurological, neurocognitive, and psychiatric symptoms. Pegvaliase, a pegylated recombinant phenylalanine ammonia lyase that metabolizes Phe, effectively reduced blood Phe in phase III studies in the United States. This multicenter,
Yoko Nakajima, Mika Ishige, Tetsuya Ito, Takashi Hamazaki, Mitsuhiro Kuwahara, Lawrence Lee, Haruo Shintaku   +6 more
wiley   +1 more source